The data we reported in this manuscript indicate that cell surface expression of the NKG2D ligands MICA and MICB is upregulated after inhibition of NAE in human MM cell lines, and in malignant plasma cells isolated from the bone marrow of MM patients (Figs. 1–3). The gene discussed is MICB; the disease is Miyoshi myopathy.